Skip to main content
SpringerLink
Log in

Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Speiser P.W., Dupont B., Rubinstein P., Piazza A., Kastelan A., New M.I. High frequency of nonclassical steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 37: 650, 1985.

    PubMed Central  PubMed  CAS  Google Scholar 

  2. Cobin R.H., Futterweit W., Fiedler R.P., Thornton J.C. Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness. Fertil. Steril. 44: 224, 1985.

    PubMed  CAS  Google Scholar 

  3. Pang S., Lerner A.J., Stoner E., Levine L.S., Oberfield S.E., Engel I., New M.I. Late-onset adrenal steroid 3β-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women. J. Clin. Endocrinol. Metab. 60: 428, 1985.

    Article  PubMed  CAS  Google Scholar 

  4. Azziz R., Zacur H.A. 21-Hydroxylase Deficiency in female hyperandrogenism: Screening and Diagnosis. J. Clin. Endocrinol. Metab. 69: 577, 1989.

    Article  PubMed  CAS  Google Scholar 

  5. Azziz R., Bradley Jr. E.L., Potter H.D., Boots L.R. 3β-hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am. J. Obstet. Gynecol. 168: 889, 1993.

    Article  PubMed  CAS  Google Scholar 

  6. Chetkowski R.J., DeFazio J., Shamonki I., Judd H.L., Chang R.J. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J. Clin. Endocrinol. Metab. 58: 595, 1984.

    Article  PubMed  CAS  Google Scholar 

  7. Innanen V.T., Vale J.M. Assessment of the one hour adrenocorticotrophic hormone test in the diagnosis of attenuated 21-hydroxylase deficiency. J. Clin. Pathol. 43: 493, 1990.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  8. McLaughlin B., Barrett P., Finch T., Devlin JG. Late onset adrenal hyperplasia in a group of Irish females who presented with hirsutism, irregular menses and/or cystic acne. Clin. Endocrinol. 32: 57, 1990.

    Article  CAS  Google Scholar 

  9. Kutteenn F., Couillin P., Girard F., Billaud L., Vincens M., Boucekkine C., Thalabard J. C., Maudelonde T., Spritzer P., Mowszowics I., Boue A., Mauvais-Jarvis P. Late-onset adrenal hyperplasia in hirsutism. N. Engl. J. Med. 313: 224, 1985.

    Article  Google Scholar 

  10. Carmina E., Malizia G., Janni A. Prevalence of late-onset 21-hydroxylase deficiency in hirsutism of western sicily. J. Endocrinol. Invest. 10: 75, 1987.

    Google Scholar 

  11. Motta P., Catania A., Airaghil, Mangone I., Cantalamessa L., Zanussi C. Prevalence of late-onset adrenal hyperplasia in postmenarchal hirsutism. J. Endocrinol. Invest. 11: 675, 1988.

    Article  PubMed  CAS  Google Scholar 

  12. Mithal A., Ammini A.C., Godbole M.M., Khurana M.L., Raj D., Karmarkar M.G., Ahuja M.M.S. Late-onset adrenal hyperplasia in North Indian hirsute women. Horm. Res. 30: 1, 1988.

    Article  PubMed  CAS  Google Scholar 

  13. Khandekar S., Lata V., Dash R.J. Screening for late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Indian J. Med. Res. 92: 79, 1990.

    PubMed  CAS  Google Scholar 

  14. Arnaout M.A. Late-onset congenital adrenal hyperplasia in women with hirsutism. Eur. J. Clin. Invest. 22: 651, 1992.

    Article  PubMed  CAS  Google Scholar 

  15. Eldar-Geva T., Hurwitz A., Vecsei P., Palti Z., Milwidsky A., Rosier A. Secondary biosynthetic defects in women with late-onset congenital adrenal hyperplasia. N. Engl. J. Med. 323: 855, 1990.

    Article  PubMed  CAS  Google Scholar 

  16. Speiser P.W., Serrat J., New M.I., Gertner J.M. Insulin insensitivity in adrenal hyperplasia due to non-classical steroid 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 75: 1421, 1992.

    PubMed  CAS  Google Scholar 

  17. Levin J.H., Carmina E., Lobo R.A. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia? Fertil. Steril. 56: 635, 1991.

    PubMed  CAS  Google Scholar 

  18. Azziz R., Dewailly D., Owerbach D. Non-classic adrenal hyperplasia: Current concepts. J. Clin. Endocrinol. Metab. 78: 810, 1994.

    PubMed  CAS  Google Scholar 

  19. Dewailly D., Vantyghem-Haudiquet MC., Sainsard C., Buvat J., Cappoen JP., Ardaens K., Racadot A., Lefebvre J., Fossati P. Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 63: 418, 1986.

    Article  PubMed  CAS  Google Scholar 

  20. Levine L.S., Dupont B., Lorenzen F., Pang S., Pollack M., Oberfield S.E., Kohn B., Lerner A., Cacciari E., Mantero F., Cassio A., Scaroni C., Chiumello G., Rondanini G.F., Gargantini L., Migliori C., Pintor C., Tato L., Barboni F., New M.I. Cryptic 21-hydroxylase deficiency in families of patients with classical congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 51: 1316, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Auchterlonie I.A., Cameron J., Wallace A.M., Rudd B.T., Hudson M., Smail P.J. Pre-pubertal gynaecomastia as the presenting feature of lateonset 21-hydroxylase deficiency. Horm. Res. 22: 94, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. New M.I., Gertner J.M., Speiser P.W., Del Balzo P. Growth and final height in classical and nonclassical 21-hydroxylase deficiency. J. Endocrinol. Invest. 12: 91, 1989.

    PubMed  CAS  Google Scholar 

  23. Augarten A., Weissenberg R., Pariente C., Sack J. Reversible male infertility in late onset congenital hyperplasia. J. Endocrinol. Invest. 14: 237, 1991.

    Article  PubMed  CAS  Google Scholar 

  24. Miller W.L. Molecular biology of steroid hormone synthesis. Endocr. Rev. 9: 295, 1988.

    Article  PubMed  CAS  Google Scholar 

  25. Miller W.L. Genetics, diagnosis, and management of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 78: 241, 1994.

    PubMed  CAS  Google Scholar 

  26. Knochenhauer E.S., Decanter C., Cortet-Rudelli C., Morel Y., Conway-Myers B.A., Dewailly D., Azziz R. Genotype in women with 21-hydroxylase (21-OH) deficient nonclassic adrenal hyperplasia (NCAH). Endocrine Society, P1–369, 1996 (Abstract).

  27. Witchel S.F., Bhamidipati D.K., Hoffman E.P., Cohen J.B. Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 81: 4081, 1996.

    PubMed  CAS  Google Scholar 

  28. Wassarman D.A., Steitz J.A. Interactions of small nuclear RNA’s with precursor messenger RNA during in vitro splicing. Science 257: 1918, 1992.

    Article  PubMed  CAS  Google Scholar 

  29. Carrera P., Bordone L., Azzani T., Brunelli V., Garancini M.P., Chiumello G., Ferrari M. Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency. Hum. Genet. 98: 662, 1996.

    Article  PubMed  CAS  Google Scholar 

  30. Helmberg A., Tusie-Luna M.T., Tabarelli M., Kofler R., White P.C. R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficience that are not apparent gene conversions. Mol. Endocrinol. 6: 1318, 1992.

    PubMed  CAS  Google Scholar 

  31. Morel Y., Miller W.L. Clinical and molecular genetics of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Adv. Hum. Genet. 20: 1, 1991.

    PubMed  CAS  Google Scholar 

  32. Chiou S.H., Hu M.C., Chung B. A missense mutation of Ile 172 to Asn or Arg 356 to Trp causes steriod 21-hydroxylase deficiency. J. Biol. Chem. 256: 3549, 1990.

    Google Scholar 

  33. Higashi Y., Hiromasa T., Tanae A., et al. Effects of individual mutations in the P-450c21 pseudogene on P-450c21 activity and their distribution in patient genomes of congenital steroid 21-hydroxylase deficiency. J. Biochem. 109: 638, 1991.

    PubMed  CAS  Google Scholar 

  34. Wu D.A., Chung B. Mutations of P450c21 (steroid 21-hydroxylase) at Cys428, Val281, or Ser268 result in complete, partial, or no loss of enzymatic activity. J. Clin. Invest. 88: 519, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  35. Mornet E., Crete P., Kuttenn F., et al. Distribution of deletions and seven point mutations on CYP21B genes in three clinical forms of steroid 21-hydroxylase deficiency. Am. J. Hum. Genet. 48: 79, 1991.

    PubMed Central  PubMed  CAS  Google Scholar 

  36. Speiser P.W., Dupont J., Zhu D., Serrat J., Buegeleisen M., Tulsie-Luna M.T., Lesser M., New M.I. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Invest. 90: 584, 1992.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  37. Owerbach D., Sherman L., Ballard A.L., Azziz R. Pro 453 to Ser mutation in CYP21 is associated with nonclassical steroid 21-hydroxylase deficiency. Mol. Endocrinol. 6: 1211, 1992.

    PubMed  CAS  Google Scholar 

  38. Bobba A., Iolascon A., Giannattasio S., Albrizio M., Sinisi A., Prisco F., Schettini F., Marra E. Characterization of CAH alleles with non-radioactive DNA single strand conformation polymorphism analysis of the CYP21 gene. J. Med. Genet. 34: 223, 1997.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  39. Owerbach D., Ballard A.L., Drazin M.B. Salt-wasting congenital adrenal hyperplasia: Detection and Characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using polymerase chain reaction. J. Clin. Endocrinol. Metab. 74: 553, 1992.

    PubMed  CAS  Google Scholar 

  40. Wilson R.C., Cheng K.C., Mercardo A.B., New M.I. Rapid deoxyribbonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene. J. Clin. Endocrinol. Metab. 80: 1635, 1995.

    PubMed  CAS  Google Scholar 

  41. Knochenhauer E.S., Cortet-Rudelli C., Cunningham R.D., Conway-Myers B.A., Dewailly D., Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J. Clin. Endocrinol. Metab. 82: 479, 1997.

    PubMed  CAS  Google Scholar 

  42. Azziz R., Slayden S.M. Mechanisms of steroid excess in 21-hydroxylase deficient non-classic adrenal hyperplasia. J. Soc. Gynecol. Invest. 3: 297, 1996.

    Article  CAS  Google Scholar 

  43. Sydnor K.L., Kelley V.C., Raile R.B., Ely R.S., Sayers G. Blood adrenocorticotrophin in children with congenital adrenal hyperplasia. Proc. Soc. Exp. Biol. Med. 82: 695, 1953.

    Article  CAS  Google Scholar 

  44. Cacciari E., Cicognani A., Pirazzoli P., Tassoni P., Zappulla F., Salardi, Bernardi F., Mazzanti L., Vianelli P. GH, ACTH, TSH, LH, and FSH reserve in prepubertal girls with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 43: 1146, 1976.

    Article  PubMed  CAS  Google Scholar 

  45. Richards G.E., Grumbach M.M., Kaplan S.L., Conte F.A. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 47: 1208, 1978.

    Article  PubMed  CAS  Google Scholar 

  46. Moreira A.C., Elias L.L.K. Pituitary-adrenal responsestocorticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 74: 198, 1992.

    PubMed  CAS  Google Scholar 

  47. Feuillan P., Pang S., Schürmeyer T., Avgerinos P.C., Chrousos G.P. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 67: 154, 1988.

    Article  PubMed  CAS  Google Scholar 

  48. Carmina E., Lobo R. Pituitary-adrenal responses to corticotropin-releasing factor in late onset 21-hydroxylase deficiency. Fertil. Steril. 54: 79, 1990.

    PubMed  CAS  Google Scholar 

  49. Ghizzoni L., Bernasconi S., Virdis R., Vottero A., Ziveri M., Volta C., Iughetti L., Giovannelli G. Dynamics of 24-hour pulsatile cortisol, 17-hydroxyprogesterone, and androstenedione release in prepubertal patients with nonclassic 21-hydroxylase deficiency and normal prepubertal children. Metabolism 43: 372, 1994.

    Article  PubMed  CAS  Google Scholar 

  50. Azziz R., Kenney P.H. Magnetic resonance imaging of the adrenal gland in women with late-onset adrenal hyperplasia. Fertil. Steril. 56: 142, 1991.

    PubMed  CAS  Google Scholar 

  51. Kater C.E., Biglieri E.G., Wajchenberg B.E. Effects of continued adrenal corticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical symbol virilizing types of 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 60: 1057, 1985.

    Article  PubMed  CAS  Google Scholar 

  52. Waterman M.R., Mason J.I., Zuber M.X., Lorence M.C., Clark B.J., Trant J.M., Barnes H.J., Simpson E.R., Estabrook R.W. Expression of P-450 enzyme activities in heterologous cells by transfection. Arch. Toxicol. 13: 155, 1989

    Article  CAS  Google Scholar 

  53. Lin D., Harikrishna J.A., Moore C.C.D., Jones K.L., Miller W.L. Missense mutation Ser106 Pro causes 17α-hydroxylase deficiency. J. Biol. Chem. 266: 15992.

  54. Lobo R.A., Goebelsmann U. Adult manifestation of congenital adrenal hyperplasia due to incomplete 21-hydroxylase deficiency mimicking polycistic ovarian disease. Am. J. Obstet. Gynecol. 138: 720, 1980.

    PubMed  CAS  Google Scholar 

  55. Chrousos G.P., Loriaux D.L., Mann D.L., Curtler G.B. Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease: An allelic variant of congenital virilizing adrenal hyperplasia with a milder enzymatic defect. Ann. Intern. Med. 96: 143, 1982.

    Article  PubMed  CAS  Google Scholar 

  56. Carmina E., Malizia G., Pagano M., Janni A. Prevalence of late-onset 11 beta-hydroxylase deficiency in hirsute patients. J. Endocrinol. Invest. 11: 595, 1988.

    Article  PubMed  CAS  Google Scholar 

  57. Schram P., Zerah M., Mani P., Jewelewics R., Jaffe S., New M.I. Nonclassical 3β-hydroxysteroid dehydrogenase deficiency: A review of our experience with 25 female patients. Fertil. Steril. 58: 129, 1992.

    PubMed  CAS  Google Scholar 

  58. Carmina E., Lobo R.A. Ovarian suppression reduces clinical and endocrine expression of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Fertil. Steril. 62: 738, 1994.

    PubMed  CAS  Google Scholar 

  59. Azziz R., Markham S., Huth J., Smith B., Zacur H.A. Long-term follow-up of hyperandrogenic women with adrenal 21-hydroxylase deficiency. Am. Fertil. Soc. P–144, 1988 (Abstract).

  60. Schiebinger R.J., Albertson B.D., Cassorla F.G., Bowyer D.W., Geelhoed G.W., Cutler G.B., Loriaux D.L The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17, 20-desmolase. J. Clin. Invest. 67: 1177, 1981.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  61. Dickerman Z., Grant D.R., Faiman C., Winter J.S.D. Intraadrenal steroid concentrations in man: zonal differences and developmental changes. J. Clin. Endocrinol. Metab. 59: 1031, 1984.

    Article  PubMed  CAS  Google Scholar 

  62. Mellon S.H., Miller W.L. Extra-adrenal steroid 21-hydroxylase is not mediated by P450c21. J. Clin. Invest. 84: 1497, 1989.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  63. Speiser P.W., Agdere L., Veshiba H., White P.C., New M.I. Aldosterone synthesis in patients with salt-wasting congenital adrenal hyperplasia (21-hydroxylase deficiency) and complete absence of adrenal 21-hydroxylase (P450c21). N. Engl. J. Med. 3221: 145, 1991.

    Article  Google Scholar 

  64. Fiet J., Gueux B., Gourmelen M., Kuttenn F., Vexiau P., Couillin P., Pham-Huu-Trung M.T., Villette J.M., Raux-Demay M.C., Galons H., et al. Comparison of basal and adrenocorticotropin-stimulated plasma 21-desoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia. J. Clin. Endocrinol. Metab. 66: 659, 1988.

    Article  PubMed  CAS  Google Scholar 

  65. New M.I., Lorenzen F., Lerner A.J., Kohn B., Oberfield S.E., Pollack M.S., Dupont B., Stoner E., Levy D.J., Pang S., Levine L.S. Genotyping steroid 21-hydroxylase deficiency: hormonal reference data. J. Clin. Endocrinol. Metab. 57: 320, 1983.

    Article  PubMed  CAS  Google Scholar 

  66. Azziz R., Hincapie L.A., Conway-Myers B.A., Knochenhauer E.S., Fox L., Dewailly D., Cortet-Rudelli C., Boots L.R. Screening for 21-hydroxylase (21-OH) deficient non-classic adrenal hyperplasia (NCAH) in hyperandrogenic (HA) women: A prospective study. Endocrine Society, OR03-6 (Abstract).

  67. Gutai J.P., Kowarski A.A., Migeon C.J. The detection of the heterozygote carrier for congenital virilizing adrenal hyperplasia. J. Pediatr. 90: 924, 1977.

    Article  PubMed  CAS  Google Scholar 

  68. Azziz R., Bradley E. Jr., Huth J., Parker C.R. Jr., Zacur H.A. Acute adrenocorticotropin- (1–24) (ACTH) adrenal stimulation in eumenorrheic women: Reproducibility and effect of ACTH dose, subject weight and sampling time. J. Clin. Endocrinol. Metab. 70: 1273, 1990.

    Article  PubMed  CAS  Google Scholar 

  69. Rosenfield R.L., Lucky A.W. Dexamethasone preparation does not alter corticoid and androgen responses to adrenocorticotropin. J. Clin. Endocrinol. Metab. 60: 585, 1985.

    Article  PubMed  CAS  Google Scholar 

  70. Knochenhauer E.S., Waggoner W.T., Azziz R., Carmina E., Dewailly D., Fruzzetti F., Ibanez L., Marcondes J.A.M., Mendonca B.B., Rohmer V., Speiser P.W., Zacur H.A. Clinical features and genotype of 21-hydroxylase (21-OH) deficient non-classic adrenal hyperplasia (NCAH): A multicenter study. Endocrine Society. P1–358, 1997 (Abstract).

  71. Knochenhauer E.S., Decanter C., Cortet-Rudeli C., Weil J., Waggoner W.T., Conway-Myers B.A., Dewailly D., Azziz R. Genotype and phenotype in women with 21-hydroxylase (21-OH) deficient non-classic adrenal hyperplasia (NCAH). American Society for Reproductive Medicine. S39, O–078, 1997 (Abstract).

    Google Scholar 

  72. Azziz R., Owerbach D.M. Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation. Am. J. Obstet. Gynecol. 172: 914, 1995.

    Article  PubMed  CAS  Google Scholar 

  73. Azziz R. Abnormalities of adrenocortical steroidogenesis in the polycystic ovary syndrome. In: Azziz R., Nestler J.E., Dewailly D. (Eds.). Androgen Excess Disorders in Women. Lippincott-Raven Pub., Philadelphia, 1997, p 403.

    Google Scholar 

  74. Azziz R., Rafi A., Smith B., Bradley Jr. E., Zacur H.A. On the origin of the elevated 17-hydroxyprogesterone levels after adrenal stimulation in hyperandrogenism. J. Clin. Endocrinol. Metab. 70: 431, 1990.

    Article  PubMed  CAS  Google Scholar 

  75. Azziz R., Wells G., Boots L.R., Zacur H.A., Acton R.T. Abnormalities of 21-hydroxylase gene ratio and adrenal steroidogenesis in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to acute adrenal stimulation. J. Clin. Endocrinol. Metab. 73: 1327, 1991.

    Article  PubMed  CAS  Google Scholar 

  76. Spritzer P., Billaud L., Thalabard JC., Birman P., Mowszowicz I., Raux-Demay MC., Clair F., Kuttenn F., Mauvais-Jarvis P. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia. J. Clin. Endocrinol. Metab. 70: 642, 1990.

    Article  PubMed  CAS  Google Scholar 

  77. Feldman S., Billaud L., Thalabard J.C., Raux-Demay M.C., Mowszowicz I., Kuttenn F., Mauvais-Jarvis P. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 74: 635, 1992.

    PubMed  CAS  Google Scholar 

  78. Azziz R., Carmina E., Dewailly D., Fruzzetti F., Marcondes J.A.M., Mendonca B.B., Speiser P.W., Zacur H.A. The risk of delivering a child with classic 21-hydroxylase (21-OH) deficient adrenal hyperplasia (CAH) among women with non-classic adrenal hyperplasia (NCAH): a multicenter study. Endocrine Society. P2–656, 1996 (Abstract).

  79. Pang S., Clark A.T., Freeman L.C., Dolan L.M., Immken L., Mueller O.T., Stiff D., Shulman D.I. Maternal side-effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 75: 249, 1992.

    PubMed  CAS  Google Scholar 

  80. Temeck J.W., Pang S., Nelson C., New M.I. Genetic defects of steroidogenesis in premature pubarche. J. Clin. Endocrinol. Metab. 64: 609, 1987.

    Article  PubMed  CAS  Google Scholar 

  81. Hawkins L.A., Chasalow F.I., Blethen S.L. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea. J. Clin. Endocrinol. Metab. 74: 248, 1992.

    PubMed  CAS  Google Scholar 

  82. Moran C., Tena G., Herrera J., Bermúdez J.A., Zárate A. Heterogeneity of late-onset adrenal 3β-ol-hydroxysteroid dehydrogenase deficiency in patients with hirsutism and polycystic ovaries. Arch. Med. Res. 25: 315, 1994.

    PubMed  CAS  Google Scholar 

  83. Mathieson J., Couzinet B., Wekstein-Noel S., Nahoul K., Turpin G., Schiason G. The incidence of late-onset congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency among hirsute women. Clin. Endocrinol. 36: 383, 1992.

    Article  CAS  Google Scholar 

  84. Labrie F., Simard J., Luu-The V., Belanger A., Peletier G. Structure function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/Δ5-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues. J. Steroid Biochem. Mol. Biol. 43: 805, 1992.

    Article  PubMed  CAS  Google Scholar 

  85. Zerah M., Rheaume E., Mani P., Schram P., Simard J., Labrie F., New M.I. No evidence of mutations in the genes for type I and type II 3β-hydroxysteroid dehydrogenase (3β-HSD) in nonclassical 3β-HSD deficiency. J. Clin. Endocrinol. Metab. 79: 1811, 1994.

    PubMed  CAS  Google Scholar 

  86. Chang Y.T., Zhang L., Alkaddour H.S., Mason J.I., Lin K., Yang X., Garibaldi L.R., Bourdony C.J., Dolan L.M., Donaldson D.L. Absence of molecular defect in the type II 3β-hydroxysteroid dehydrogenase (3β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3β-HSD activity. Pediatr. Res. 37: 820, 1995

    Article  PubMed  CAS  Google Scholar 

  87. Sakkal-Alkaddour H., Zhang L., Yang X., Chang Y.T., Kappy M., Slover R.S., Jorgensen V., Pang S. Studies of 3β-hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased ACTH stimulation A5 steroid levels. J. Clin. Endocrinol. Metab. 81: 3961, 1996.

    PubMed  CAS  Google Scholar 

  88. Pang S. The molecular and clinical spectrum of 3β-hydroxysteroid dehydrogenase deficiency syndrome. Trends Endocrinol. Metab. 9: 82, 1998

    Article  PubMed  CAS  Google Scholar 

  89. Bongiovanni A.M., Kellenbenz G. The adrenogenital syndrome with deficiency of 3β-hydroxysteroid dehydrogenase. J. Clin. Invest. 41: 2086, 1962.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  90. Zachmann M., Tassinari D., Prader A. Clinical and biochemical variability of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. A study of 25 patients. J. Clin. Endocrinol. Metab. 56: 222, 1983.

    Article  PubMed  CAS  Google Scholar 

  91. Cathelineau G., Brerault J.L., Fiet J., Julien R., Dreux C., Canivet J. Adrenocortical 11 beta-hydroxylation defect in adult women with postmenarchial onset of symptoms. J. Clin. Endocrinol. Metab. 51: 287, 1980.

    Article  PubMed  CAS  Google Scholar 

  92. Azziz R., Bradley Jr. E.L., Potter H.D., Boots L.R. 3β-Hydroxysteroid dehydrogenase deficiency in hyperandrogenism. Am. J. Obstet Gynecol. 168: 889, 1993.

    Article  PubMed  CAS  Google Scholar 

  93. White P.C., Johrer K., Kofier R. Steroid 11β-hydroxylase deficiency. In: Azziz R., Nestler J.E., Dewailly D. (Eds.). Androgen excess disorders in women. Lippincott-Raven Publishers, Philadelphia, 1997, p. 193.

    Google Scholar 

  94. Joehrer K., Geley S., Strasser-Wozak E.M.C., Azziz R., Wollmann H.A., Schmitt K., Kofier R., White P. CYP11B1 mutations causing nonclassic adrenal hyperplasia due to 11β-hydroxylase deficiency. Hum. Mol. Genet. 6: 1829, 1997

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Reproductive Biology and Endocrinology, Department of Obstetrics and Gynecology, The University of Alabama at Birmingham, 618 South 20th Street, OHB 549, Birmingham, Alabama, 35294-7333, USA

    C. Morán, E. S. Knochenhauer & Ricardo Azziz M.D., M.P.H.

  2. Departments of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA

    Ricardo Azziz M.D., M.P.H.

  3. Research Unit of Reproductive Medicine, Instituto Mexicano del Seguro Social, Mexico City, Mexico

    C. Morán

Authors
  1. C. Morán
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. S. Knochenhauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ricardo Azziz M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morán, C., Knochenhauer, E.S. & Azziz, R. Non-classic adrenal hyperplasia in hyperandrogenism: A reappraisal. J Endocrinol Invest 21, 707–720 (1998). https://doi.org/10.1007/BF03350803

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350803

Key-words

Search

Navigation